Psc clinical trials

Explore recruiting psc clinical trials.

Recruiting psc studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Psc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-label study of patients with primary sclerosing cholangitis (PSC) treated with norucholic acid tablets

Germany, Netherlands, Belgium, France, Norway, Austria +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

C1091009 - A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT GROUP B STREPTOCOCCUS VACCINE IN HEALTHY PREGNANT WOMEN AND THEIR INFANTS

Finland, Netherlands, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Double-blind, randomized, placebo-controlled, phase III study comparing norursodeoxycholic acid capsules with placebo in the treatment of primary sclerosing cholangitis

Denmark, Austria, Norway, Finland, Poland, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A study to characterize the pharmacokinetic profile of norucholic acid (NCA) in patients with primary sclerosing cholangitis (PSC)

Germany, Austria, Finland, Norway

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Mass Balance Study of [14C]-IPN60250 in Healthy Adult Participants

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Prospective, Randomized, Placebo-controlled Clinical Trial of oral vancomycin in adults and young adults (15-17 years old) affected by Primary Sclerosing Cholangitis with or without Inflammatory Bowel Disease

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Psc trials by city

Psc in Toronto Psc in Vancouver Psc in Montreal Psc in Calgary Psc in Edmonton Psc in Ottawa Psc in Winnipeg Psc in Quebec City Psc in Hamilton Psc in Kitchener Psc in London Psc in Halifax Psc in New York Psc in Los Angeles Psc in Chicago Psc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease